1. 2022
  2. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort

    Dezanet, L. N. C., Kassime, R., Miailhes, P., Lascoux-Combe, C., Chas, J., Maylin, S., Gabassi, A., Rougier, H., Delaugerre, C., Lacombe, K. & Boyd, A., 15 Mar 2022, In: Clinical infectious diseases. 74, 6, p. 1012-1021 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae

    Gubenšek, U., de Laat, M., Foerster, S., Boyd, A. & van Dam, A. P., 1 Mar 2022, In: Antibiotics (Basel, Switzerland). 11, 3, 299.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study

    Coyer, L., Boyd, A., Schinkel, J., Agyemang, C., Galenkamp, H., Koopman, A. D. M., Leenstra, T., van Duijnhoven, Y. T. H. P., Moll van Charante, E. P., van den Born, B-J. H., Lok, A., Verhoeff, A., Zwinderman, A. H., Jurriaans, S., Stronks, K. & Prins, M., 1 Feb 2022, In: The Lancet Regional Health - Europe. 13, 100284.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

    van Gils, M. J., van Willigen, H. D. G., Wynberg, E., Han, A. X., van der Straten, K., Burger, J. A., Poniman, M., Oomen, M., Tejjani, K., Bouhuijs, J. H., Verveen, A., Lebbink, R., Dijkstra, M., Appelman, B., Lavell, A. H. A., Caniels, T. G., Bontjer, I., van Vught, L. A., Vlaar, A. P. J., Sikkens, J. J., & 32 othersBomers, M. K., Russell, C. A., Kootstra, N. A., Sanders, R. W., Prins, M., de Bree, G. J., de Jong, M. D., RECoVERED Study Group, Agard, I., Ayal, J., Boyd, A., Cavdar, F., Craanen, M., Davidovich, U., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., Hartman, J., Koedoot, N., van den Aardweg, J., Boeser-Nunnink, B., Moll van Charante, E., van Dort, K., Hidad, S., Jurriaans, S., Knoop, H., Lok, A., Maurer, I., Nieuwkerk, P., van Nuenen, A. & Matser, A., 18 Jan 2022, In: Cell Reports Medicine. 3, 1, 100486.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands

    de la Court, F., Boyd, A., Coyer, L., van den Elshout, M., de Vries, H. J. C., Matser, A., Hoornenborg, E., the HIV Transmission Elimination AMsterdam, H-TEAM) Consortium & Prins, M., 2022, (E-pub ahead of print) In: HIV medicine.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2021
  8. Differences in prevalence of hepatitis B virus infection and genotypes between ethnic populations in Suriname, South America

    MacDonald – Ottevanger, M. S., Boyd, A., Prins, M., van der Helm, J. J., Zijlmans, C. W. R., Hindori-Mohangoo, A. D., Harkisoen, S., Hermelijn, S. M., Brinkman, K., Codrington, J., Roosblad, J., Kort, S. A. R., Dams, E. T. M., van de Laar, T. J. W. & Vreden, S. G. S., 1 Dec 2021, In: Virology. 564, p. 53-61 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis B

    Dezanet, L. N. C., Miailhes, P., Lascoux-Combe, C., Chas, J., Maylin, S., Gabassi, A., Rougier, H., Delaugerre, C., Lacombe, K. & Boyd, A., Dec 2021, In: Liver international. 41, 12, p. 2874-2884 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...19 Next

ID: 12524562